§ 22 §8741 — International referenced rate pricing

1.
Definitions.
As used in this section, unless the context otherwise indicates, the following terms have the following meanings.
2.
Referenced rates determined.
The following provisions govern the determination of referenced rates of prescription drugs.
3.
Reporting.
By January 1, 2023, and annually thereafter, the organization shall produce and post on its publicly accessible website a report including the information required under subsection 2. The organization shall submit the report required by this subsection to the Office of Affordable Health Care established in Title 5, section 3122, the Maine Prescription Drug Affordability Board established in Title 5, section 12004‑G, subsection 14‑I and the joint standing committee of the Legislature having jurisdiction over health data reporting and prescription drug matters. The joint standing committee of the Legislature having jurisdiction over health data reporting and prescription drug matters may report out legislation based on the report to the first regular or second regular session of the Legislature, depending on the year in which the report is submitted.

Legislative History

PL 2021, c. 606, §1 (NEW).